| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 40.610 | 40.534 | 40.738 | 38.125 | 27.515 | 31.900 | 33.506 | 27.628 | 20.775 |
| Total Income - EUR | - | 40.610 | 40.534 | 40.738 | 38.125 | 28.089 | 31.900 | 33.506 | 27.628 | 20.775 |
| Total Expenses - EUR | - | 869 | 183 | 326 | 1.854 | 5.470 | 6.293 | 7.046 | 7.984 | 9.075 |
| Gross Profit/Loss - EUR | - | 39.741 | 40.351 | 40.412 | 36.271 | 22.619 | 25.607 | 26.461 | 19.644 | 11.700 |
| Net Profit/Loss - EUR | - | 38.523 | 39.135 | 39.190 | 35.314 | 22.364 | 25.295 | 26.176 | 19.373 | 11.089 |
| Employees | - | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Citomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 519 | 306 | 100 | 0 | 0 | 0 | 0 |
| Current Assets | - | 39.439 | 54.257 | 41.844 | 35.833 | 56.064 | 27.665 | 72.848 | 27.661 | 16.913 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 3.345 | 2.402 | 2.442 | 2.580 | 2.695 | 3.259 | 23.729 | 4.375 | 5.524 |
| Cash | - | 36.094 | 51.855 | 39.402 | 33.253 | 53.369 | 24.405 | 49.119 | 23.286 | 11.389 |
| Shareholders Funds | - | 38.567 | 39.835 | 39.613 | 35.596 | 24.187 | 27.112 | 26.403 | 26.895 | 7.321 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 871 | 14.422 | 2.750 | 542 | 31.978 | 552 | 46.444 | 766 | 9.592 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Citomed Srl